Synopsys (SNPS) Could Be 28% Below Fair Value Following Its AI Chip Design Push

Synopsys (SNPS) is back in focus after a string of AI centric announcements with Microsoft, AMD, Intel, and NVIDIA that target more automated chip design, verification, and advanced multi die integration.

See our latest analysis for Synopsys.

Despite the recent AI partnerships with Microsoft, AMD, Intel, and NVIDIA, Synopsys shares have come under pressure, with the 90 day share price return down 20.66% and the 1 year total shareholder return down 35.96%. This suggests that recent news is being weighed against a weaker share price trend over the year.

If these AI announcements have caught your attention and you want to see what other chip and software companies are doing in this space, now could be a good time to scan 56 AI infrastructure stocks

Synopsys has active AI collaborations with major chipmakers, yet the share price has pulled back sharply. Should you treat this weakness as a chance to buy in, or wait for a cheaper entry before the valuation section does the heavy lifting?

Most Popular Narrative: 28.4% Undervalued

Compared with Synopsys' last close of $400.82, the most followed narrative points to a fair value around $559.58, built on detailed revenue, margin and cash flow expectations.

The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems, dramatically expanding its addressable market into sectors like automotive, industrial, and aerospace. This is expected to support long-term top-line growth as more sophisticated and complex products (especially AI-powered and smart devices) require robust simulation, analysis, and EDA tools.

Read the complete narrative.

Curious what sits behind that fair value gap for Synopsys? The narrative focuses on a specific earnings ramp, firmer margins, and a higher future profit multiple. The exact mix of growth and valuation assumptions might surprise you.

Result: Fair Value of $559.58 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Synopsys still faces meaningful risks, including China related export limits and customer concentration, which could slow growth and challenge the current valuation narrative.

Find out about the key risks to this Synopsys narrative.

Another View on Synopsys Valuation

The first narrative leans heavily on future earnings and a higher profit multiple to argue that Synopsys is 28.4% undervalued at a fair value of $559.58. Yet on simple P/E, the stock looks expensive at 99.3x versus 34x for peers, 32.5x for the US Software industry, and a fair ratio of 51.2x. That gap points to real valuation risk if sentiment shifts, so which signal should investors focus on?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Given the mix of optimism and concern around Synopsys, this is a moment to move quickly and review the underlying numbers yourself. To see how those potential risks and rewards balance out, start with the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Synopsys?

If Synopsys has sharpened your focus, do not stop here. Use these curated stock ideas to pressure test your thinking and spot opportunities others might overlook.

• Target potential mispricings by scanning 51 high quality undervalued stocks that pair quality fundamentals with prices that may not fully reflect their underlying strength.
• Strengthen your focus on capital preservation by reviewing 79 resilient stocks with low risk scores that score well on resilience and lower overall risk profiles.
• Identify companies that may be less widely followed by checking the screener containing 17 high quality undiscovered gems to broaden your opportunity set.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com